Tag: Infectious Diseases
-
Spike Mutations Help SARS-CoV-2 Infect the Brain
Northwestern Medicine scientists have discovered a mutation in SARS-CoV-2, the virus that causes COVID-19, that plays a key role in its ability to infect the central nervous system, according to recent findings.
-
Study Examines Surge in RSV Cases After the COVID-19 Pandemic
The surge in RSV cases following the COVID-19 pandemic may have been, in part, caused by increased testing and changes to the RSV genome, according to a Northwestern Medicine study published in Nature Communications.
-
Tracking the Evolution of COVID-19
Scientists have developed a machine-learning approach to track the evolution of the COVID-19 virus and potentially others, according to a study published in the Proceedings of the National Academy of Sciences.
-
COVID-19 Vaccines Highly Effective for Children During Delta and Omicron Waves, Study Finds
The Pfizer BioNTech BNT162b2 vaccine was highly effective in preventing severe COVID-19 infections in children and adolescents during the Delta and Omicron variants, according to a large, national study recently published in the Annals of Internal Medicine.
-
Exploring How Antibiotic-Resistant Bacteria Become Aggressive
Some strains of an antibiotic-resistant bacteria may not turn out to be as aggressive as previously thought, according to a Northwestern Medicine study recently published in Nature Communications.
-
Global Health Day Highlights Pandemic, HIV Research
Northwestern investigators, faculty, students and community partners came together to share and celebrate global health research, education and outreach as part of the Robert J. Havey, MD Institute for Global Health’s 12th annual Global Health Day.
-
Gene Linked to HIV Viral Load in People of African Ancestry
Naturally occurring variations near the human gene CHD1L may be linked to lower HIV-1 viral load in people of African ancestry, according to a new international, multicenter study published in Nature.
-
Study Examines Performance of Serial COVID Testing
Testing performance of rapid antigen tests for SARS-CoV-2 improved for both asymptomatic and symptomatic patients after testing multiple times in 48-hour intervals, according to findings published in the Annals of Internal Medicine.
-
Northwestern Investigators Lead Global Research on Antimicrobial Resistance
Northwestern investigators have formed an interdisciplinary group to address the global issue of antimicrobial resistance.
-
Novel Monoclonal Antibody Therapy for SARS-CoV-2
Targeting internal proteins instead of spike proteins may be a promising strategy for monoclonal antibody therapy to combat SARS-CoV-2, the virus that causes COVID-19.
